. 2022 Mar 30;26(1):78–87. doi: 10.5114/wo.2022.115678

Table 5.

Clinical outcomes of patients in relation to expression markers

Clinical outcome		Total, N = 61		CK19				p-value	OCT4				p-value
		Total, N = 61		Negative, n = 23		Positive, n = 38			Negative, n = 24		Positive, n = 37
		n	%	n	%	n	%		n	%	n	%
Local recurrence	No	53	86.90	19	82.60	34	89.50	0.441	23	95.80	30	81.10	0.095
Local recurrence	Yes	8	13.10	4	17.40	4	10.50	0.441	1	4.20	7	18.90	0.095
Progression	No	49	80.30	19	82.60	30	78.90	0.727	23	95.80	26	70.30	0.014
Progression	Yes	12	19.70	4	17.40	8	21.10	0.727	1	4.20	11	29.70	0.014
Death	No	52	85.20	22	95.70	30	78.90	0.075	24	100.00	28	75.70	0.009
Death	Yes	9	14.80	1	4.30	8	21.10	0.075	0	0.00	9	24.30	0.009